Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greil

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Current Topics in Microbiology and Immunology|January 1, 1992
Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiationR Greil, P Loidl, B Fasching, et al.
Blood|July 1, 1991
Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysisR Greil, B Fasching, P Loidl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patientsM F Fey, R Greil, L M Jost, et al.
British Journal of Haematology|February 1, 1986
Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomasR Greil, C Gattringer, W Knapp, et al.
Pathology, Research and Practice|November 5, 1999
Thymic Hodgkin's disease--a histological and immunohistochemical study of three casesJ Krugmann, H Feichtinger, R Greil, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 29, 2004
Biomarkers in non-small cell lung cancer preventionW Hilbe, S Dirnhofer, R Greil, et al.
Blut|July 1, 1986
In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypesG Gattringer, R Greil, T Radaszkiewicz, et al.
Expert Review of Anticancer Therapy|September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinomaF Stenner-Liewen, V Grünwald, R Greil, et al.
Pathology, Research and Practice|October 1, 1995
Gastric malt lymphoma with crystalline immunoglobulin inclusions and secondary immunoblastic lymphoma in a cervical lymph nodeF Fend, C Gabl, A Hittmair, et al.
Onkologie|April 1, 1986
[Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance]H Huber, J Thaler, R Greil, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Current Topics in Microbiology and Immunology|January 1, 1992
Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiationR Greil, P Loidl, B Fasching, et al.
Blood|July 1, 1991
Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysisR Greil, B Fasching, P Loidl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patientsM F Fey, R Greil, L M Jost, et al.
British Journal of Haematology|February 1, 1986
Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomasR Greil, C Gattringer, W Knapp, et al.
Pathology, Research and Practice|November 5, 1999
Thymic Hodgkin's disease--a histological and immunohistochemical study of three casesJ Krugmann, H Feichtinger, R Greil, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 29, 2004
Biomarkers in non-small cell lung cancer preventionW Hilbe, S Dirnhofer, R Greil, et al.
Blut|July 1, 1986
In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypesG Gattringer, R Greil, T Radaszkiewicz, et al.
Expert Review of Anticancer Therapy|September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinomaF Stenner-Liewen, V Grünwald, R Greil, et al.
Pathology, Research and Practice|October 1, 1995
Gastric malt lymphoma with crystalline immunoglobulin inclusions and secondary immunoblastic lymphoma in a cervical lymph nodeF Fend, C Gabl, A Hittmair, et al.
Onkologie|April 1, 1986
[Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance]H Huber, J Thaler, R Greil, et al.
Pageof 15